{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:21:46Z","timestamp":1788456106592,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neurot.2024.e00481","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T19:39:20Z","timestamp":1731526760000},"page":"e00481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sodium butyrate restored TRESK current controlling neuronal hyperexcitability in a mouse model of oxaliplatin-induced peripheral neuropathic pain"],"prefix":"10.1016","volume":"22","author":[{"given":"Idy H.T.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kele","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huarong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Gin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William K.K.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.V.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2024.e00481_bib1","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"I.\u00a0Multicenter international study of oxaliplatin\/5-fluorouracil\/leucovorin in the adjuvant treatment of colon cancer, oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andre","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.neurot.2024.e00481_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12885-018-4185-0","article-title":"The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review","volume":"18","author":"Gebremedhn","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neurot.2024.e00481_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12885-019-5302-4","article-title":"Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy","volume":"19","author":"Molassiotis","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neurot.2024.e00481_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/0284186X.2014.995775","article-title":"Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives","volume":"54","author":"Ewertz","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.neurot.2024.e00481_bib5","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00520-014-2255-7","article-title":"Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review","volume":"22","author":"Mols","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.neurot.2024.e00481_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/jns.12432","article-title":"Platinum accumulation in oxaliplatin-induced peripheral neuropathy","volume":"26","author":"Wei","year":"2021","journal-title":"J\u00a0Peripher Nerv Syst"},{"key":"10.1016\/j.neurot.2024.e00481_bib7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuro.2006.04.010","article-title":"Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding","volume":"27","author":"Ta","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neurot.2024.e00481_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2018.11.016","article-title":"Dorsal root ganglion explants derived from chemotherapy-treated mice have reduced neurite outgrowth in culture","volume":"694","author":"Livni","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurot.2024.e00481_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.02.007","article-title":"Comparative transcriptome of dorsal root ganglia reveals distinct etiologies of paclitaxel- and oxaliplatin-induced peripheral neuropathy in rats","volume":"516","author":"Sun","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurot.2024.e00481_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/emmm.201100134","article-title":"Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors","volume":"3","author":"Descoeur","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.neurot.2024.e00481_bib11","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1152\/jn.2001.85.5.2293","article-title":"A\u00a0possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels","volume":"85","author":"Grolleau","year":"2001","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.neurot.2024.e00481_bib12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.neurot.2024.e00481_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","article-title":"HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis","volume":"13","author":"Saha","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neurot.2024.e00481_bib14","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1007\/s12035-021-02361-6","article-title":"Epigenetics involvement in oxaliplatin-induced potassium channel transcriptional downregulation and hypersensitivity","volume":"58","author":"Pereira","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neurot.2024.e00481_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010098","article-title":"The class I HDAC inhibitor, MS-275, prevents oxaliplatin-induced chronic neuropathy and potentiates its antiproliferative activity in mice","volume":"23","author":"Lamoine","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2024.e00481_bib16","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.pain.2013.05.021","article-title":"HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain","volume":"154","author":"Denk","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.neurot.2024.e00481_bib17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/ard-2021-221269","article-title":"Targeting FoxO transcription factors with HDAC inhibitors for the treatment of osteoarthritis","volume":"82","author":"Ohzono","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.neurot.2024.e00481_bib18","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s13311-022-01243-6","article-title":"Dual HDAC\/BRD4 inhibitors relieves neuropathic pain by attenuating inflammatory response in microglia after spared nerve injury","volume":"19","author":"Borgonetti","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2024.e00481_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbi.2021.12.005","article-title":"An HDAC6 inhibitor reverses chemotherapy-induced mechanical hypersensitivity via an IL-10 and macrophage dependent pathway","volume":"100","author":"Zhang","year":"2022","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurot.2024.e00481_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154670","article-title":"Zingiberene, a non-zinc-binding class I HDAC inhibitor: a novel strategy for the management of neuropathic pain","volume":"111","author":"Borgonetti","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neurot.2024.e00481_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12974-020-01740-5","article-title":"Suppression of histone deacetylases by SAHA relieves bone cancer pain in rats via inhibiting activation of glial cells in spinal dorsal horn and dorsal root ganglia","volume":"17","author":"He","year":"2020","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurot.2024.e00481_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.phrs.2015.11.026","article-title":"Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice","volume":"103","author":"Russo","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.neurot.2024.e00481_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110061","article-title":"The immunomodulatory effects of ethosuximide and sodium butyrate on experimentally induced fibromyalgia: the interaction between IL-4, synaptophysin, and TGF-beta1\/NF-kappaB signaling","volume":"118","author":"Abd Elmaaboud","year":"2023","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.neurot.2024.e00481_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jfma.2013.05.013","article-title":"Attenuation of neuropathic pain by sodium butyrate in an experimental model of chronic constriction injury in rats","volume":"113","author":"Kukkar","year":"2014","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.neurot.2024.e00481_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094847","article-title":"Supplementation with SCFAs Re-establishes microbiota composition and attenuates hyperalgesia and pain in a mouse model of NTG-induced migraine","volume":"23","author":"Lanza","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2024.e00481_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56132-4","article-title":"Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome","volume":"9","author":"Nozu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2024.e00481_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1207911","article-title":"Lactobacillus rhamnosus GG and butyrate supplementation in rats with bone cancer reduces mechanical allodynia and increases expression of mu-opioid receptor in the spinal cord","volume":"16","author":"Yuan","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.neurot.2024.e00481_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44857-2","article-title":"Short-chain fatty acid, butyrate prevents morphine-and paclitaxel-induced nociceptive hypersensitivity","volume":"13","author":"Jessup","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2024.e00481_bib29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1463-1318.2012.03152.x","article-title":"Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome","volume":"15","author":"Banasiewicz","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.neurot.2024.e00481_bib30","first-page":"5244","article-title":"Sodium propionate and sodium butyrate effects on histone deacetylase (HDAC) activity, histone acetylation, and inflammatory gene expression in bovine mammary epithelial cells","volume":"96","author":"Silva","year":"2018","journal-title":"J\u00a0Anim Sci"},{"key":"10.1016\/j.neurot.2024.e00481_bib31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","article-title":"Methods used to evaluate pain behaviors in rodents","volume":"10","author":"Deuis","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.neurot.2024.e00481_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919874192","article-title":"Front and hind paw differential analgesic effects of amitriptyline, gabapentin, ibuprofen, and URB937 on mechanical and cold sensitivity in cisplatin-induced neuropathy","volume":"15","author":"Thompson","year":"2019","journal-title":"Mol Pain"},{"key":"10.1016\/j.neurot.2024.e00481_bib33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1113\/jphysiol.2007.145649","article-title":"TRESK two-pore-domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones","volume":"585","author":"Dobler","year":"2007","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.neurot.2024.e00481_bib34","doi-asserted-by":"crossref","first-page":"12810","DOI":"10.1523\/JNEUROSCI.1237-13.2013","article-title":"Functional analysis of a migraine-associated TRESK K+ channel mutation","volume":"33","author":"Liu","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.neurot.2024.e00481_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1744-8069-7-30","article-title":"TRESK channel contribution to nociceptive sensory neurons excitability: modulation by nerve injury","volume":"7","author":"Tulleuda","year":"2011","journal-title":"Mol Pain"},{"key":"10.1016\/j.neurot.2024.e00481_bib36","article-title":"Over-expression of TRESK K(+) channels reduces the excitability of trigeminal ganglion nociceptors","volume":"9","author":"Guo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2024.e00481_bib37","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1152\/jn.00551.2011","article-title":"Effects of familial hemiplegic migraine type 1 mutation T666M on voltage-gated calcium channel activities in trigeminal ganglion neurons","volume":"107","author":"Tao","year":"2012","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.neurot.2024.e00481_bib38","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1124\/mol.108.054346","article-title":"Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain","volume":"75","author":"Chiechio","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00481_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1744-8069-6-51","article-title":"Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia","volume":"6","author":"Bai","year":"2010","journal-title":"Mol Pain"},{"key":"10.1016\/j.neurot.2024.e00481_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pain.2009.03.024","article-title":"Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study","volume":"144","author":"Attal","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neurot.2024.e00481_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.566418","article-title":"K(+) channels in primary afferents and their role in nerve injury-induced pain","volume":"14","author":"Smith","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.neurot.2024.e00481_bib42","doi-asserted-by":"crossref","first-page":"C138","DOI":"10.1152\/ajpcell.00629.2005","article-title":"TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background K+ channels in dorsal root ganglion neurons","volume":"291","author":"Kang","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.neurot.2024.e00481_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/bja\/aex229","article-title":"Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review","volume":"119","author":"Flatters","year":"2017","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.neurot.2024.e00481_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917747425","article-title":"Activation of STAT3-mediated CXCL12 up-regulation in the dorsal root ganglion contributes to oxaliplatin-induced chronic pain","volume":"13","author":"Li","year":"2017","journal-title":"Mol Pain"},{"key":"10.1016\/j.neurot.2024.e00481_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cyto.2012.03.027","article-title":"Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy","volume":"59","author":"Wang","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.neurot.2024.e00481_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1744-8069-8-14","article-title":"The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states","volume":"8","author":"Tochiki","year":"2012","journal-title":"Mol Pain"},{"key":"10.1016\/j.neurot.2024.e00481_bib47","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/nn.4165","article-title":"G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition","volume":"18","author":"Laumet","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2024.e00481_bib48","first-page":"419","article-title":"G\u00a0protein-gated inwardly rectifying potassium channel subunit 3 is upregulated in rat DRGs and spinal cord after peripheral nerve injury","volume":"13","author":"Lyu","year":"2020","journal-title":"J\u00a0Pain Res"},{"key":"10.1016\/j.neurot.2024.e00481_bib49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/FPC.0b013e3282f55ab2","article-title":"Quantitative trait locus and computational mapping identifies Kcnj9 (GIRK3) as a candidate gene affecting analgesia from multiple drug classes","volume":"18","author":"Smith","year":"2008","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.neurot.2024.e00481_bib50","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1113\/JP279203","article-title":"TRESK background K(+) channel deletion selectively uncovers enhanced mechanical and cold sensitivity","volume":"598","author":"Castellanos","year":"2020","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.neurot.2024.e00481_bib51","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd3777","article-title":"G\u00a0protein-coupled receptors for energy metabolites as new therapeutic targets","volume":"11","author":"Blad","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neurot.2024.e00481_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107388","article-title":"Butyrate increases intracellular calcium levels and enhances growth hormone release from rat anterior pituitary cells via the G-protein-coupled receptors GPR41 and 43","volume":"9","author":"Miletta","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2024.e00481_bib53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/0271678X20910533","article-title":"Sodium butyrate attenuated neuronal apoptosis via GPR41\/Gbetagamma\/PI3K\/Akt pathway after MCAO in rats","volume":"41","author":"Zhou","year":"2021","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.neurot.2024.e00481_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101598","article-title":"Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer","volume":"27","author":"Shuwen","year":"2023","journal-title":"Transl Oncol"},{"key":"10.1016\/j.neurot.2024.e00481_bib55","article-title":"Combining sodium butyrate with cisplatin increases the apoptosis of gastric cancer in vivo and in vitro via the mitochondrial apoptosis pathway","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00481_bib56","doi-asserted-by":"crossref","first-page":"26482","DOI":"10.1073\/pnas.2006065117","article-title":"Fecal transplantation and butyrate improve neuropathic pain, modify immune cell profile, and gene expression in the PNS of obese mice","volume":"117","author":"Bonomo","year":"2020","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924001685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924001685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:25:16Z","timestamp":1740140716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924001685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1878747924001685"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00481","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium butyrate restored TRESK current controlling neuronal hyperexcitability in a mouse model of oxaliplatin-induced peripheral neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00481"}}